Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBTG Share News (BTG)

  • There is currently no data for BTG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: BG And Shell Rise On Chinese Regulator Approval

Mon, 14th Dec 2015 08:38

LONDON (Alliance News) - London stocks opened higher Monday, with shares in BG Group and Royal Dutch Shell benefiting from the approval of Shell's takeover by Chinese regulators.

The FTSE 100 index opened higher, off the late-September lows it touched on Friday, up 0.7% at 5,996.40 points. The FTSE 250 was up 0.4% at 16,944.78, while the AIM All-Share was down 0.1% at 724.64.

In Europe, the French CAC 40 index was up 0.5% and the German DAX 30 up 0.6%.

BG Group and Royal Dutch Shell 'A' shares, were up 1.9% and 0.4%, respectively, after Shell said its GBP47.0 billion takeover of BG has secured approval from regulators in China, providing the final pre-conditional approval required for the merger.

The Chinese Ministry of Commerce gave its unconditional clearance for the deal, adding to the approvals the pair already received in Brazil, the European Union and Australia.

"This is a strategic deal that will make Shell a more profitable and resilient company in a world where oil and gas prices could remain lower for some time. We will now seek approval from both sets of shareholders as we move towards deal completion in early 2016," said Ben van Beurden, Shell's chief executive.

Blue-chip Old Mutual, up 7.1%, and FTSE 250-listed Investec, up 10%, were recovering some ground after both dropping 11% on Friday, adding to losses seen on Thursday. The two stocks suffered as the South African rand traded near record lows against the dollar following the dismissal of South African Finance Minister Nhlanhla Nene.

Both companies derive a great deal of their earnings from South Africa, and the depreciation of the rand reduces the translation of rand earnings into sterling.

Power station operator Drax Group was among the best performers in the FTSE 250, up 6.7% after being upgraded to Buy from Sell by Goldman Sachs.

Specialty pharmaceuticals company BTG was up 2.7% after it said its PneumRx coil implant for patients with homogeneous or heterogeneous severe emphysema met all of its primary and secondary endpoints in its recent clinical study RENEW.

Additionally, the company received 510k clearance from the US Food and Drug Administration for its LC Bead LUMI, meaning it has permission to market the product. The LC Bead device is used to block abnormal blood vessels, for use in hypervascular tumours and arteriovenous malformations.

LC Bead LUMI, the latest iteration of this device, allows for real-time visible confirmation of the bead location.

Oil prices were still under pressure after the open Monday, with Brent oil price priced at USD37.89 a barrel, a low it hasn't seen since December 2008. At the close on Friday, Brent stood at USD38.18 a barrel. West Texas Intermediate was at USD35.49 a barrel shortly after the London open.

The new lows were made after the Organisation of the Petroleum Exporting Countries said on Thursday last week that its members pumped more oil in November than in any month since late 2008. The cartel also forecast little increase in demand for its crude next year.

This followed an announcement the week before, in which OPEC said it will maintain oil production at current levels and refrained from outlining a production ceiling.

Though clearly the main event this week will be the US Federal Reserve interest rate decision on Wednesday, there are still three days until Janet Yellen announces the Federal Open Market Committee's decision to press, or not to press, the rate-hike button.

Ahead of that, the PBoC last week hinted that it would reduce the yuan's link to the dollar. The China Foreign Exchange Trade System, a unit of PBoC, introduced a new yuan index on Friday that measures the value of currency against a basket of currencies instead of the dollar.

"Could Beijing's suggestion about pegging the yuan to a basket rather than the dollar, and the currency falling to a fresh four-year low, see Yellen & Co spooked again? Or after the [European Central Bank President Mario] Draghi disappointment [after releasing its easing measures two weeks ago], has the issue of credibility become too much to risk?," asked Michael van Dulken, analyst at Accendo Markets.

In Asia on Monday the Japanese Nikkei 225 index closed down 1.8%. In China, the Shanghai Composite ended up 2.5%, while the Hang Seng index in Hong Kong finished down 0.7%.

In a light economic calendar Monday, eurozone industrial production, due at 1000 GMT, and a speech from European Central Bank President Mario Draghi in Italy are likely to attract some market attention Monday.

"We look for a small rise of 0.3% month-on-month for euro area industrial production in October. German output, already released, disappointed with a smaller-than-expected rise of 0.1% (excluding construction), potentially reflecting ongoing soft external demand, but outturns were somewhat stronger in France and Italy," said Lloyds Bank senior economist Hann-Ju Ho.

"The context for any comments on policy by Mr Draghi will be the lingering disappointment from the increase in policy stimulus by the ECB on December 3," added the Lloyds economist. "Some ECB speakers have since put the blame on unrealistic expectations of market participants, rather than faulty communication by the central bank. Mr Draghi could reiterate that there can be no limit to policy easing in order to meet the ECB's inflation goal."

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 Apr 2015 08:51

BTG expects higher annual revenue, hikes guidance for 2015

Healthcare group BTG said it expected annual revenue to be "slightly" higher than indicated earlier this year. The FTSE 250 group said expected revenue for the year ended 31 March would be above the previous guidance it provided of £345m to £360m, including revenue from the PneumRx acquisition it co

Read more
2 Apr 2015 07:25

LONDON MORNING BRIEFING: M&S UK Performance Beats Hopes

Read more
2 Apr 2015 06:37

MARKET COMMENT: FTSE 100 Seen Lower; Oil Prices Came Down Overnight

Read more
2 Apr 2015 06:23

BTG Says Revenue To Beat Hopes, Continue Growing Strongly

Read more
1 Apr 2015 10:59

BTG starts selling its products to European hospitals

Healthcare company BTG said it started selling its drug-eluting bead and embolisation products to customers in 11 European countries. The products, DC Bead and Bead Block, will be sold directly to hospitals in Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Portugal, Switzerland, Spa

Read more
1 Apr 2015 07:18

LONDON MORNING BRIEFING: M&A In Focus In Mid-Cap Sector

Read more
1 Apr 2015 06:45

BTG Starts Direct Sales Of DC Bead, Bead Block Products In Europe

Read more
19 Feb 2015 09:00

BTG Eyes US Investors With Launch Of ADR Programme (ALLISS)

Read more
5 Feb 2015 15:33

BTG boosts full-year guidance thanks to PneumRx acquisition

After currencies moved in its favour and the completion of a recent acquisition, healthcare group BTG has raised its guidance for full-year revenue. Full-year revenue is now expected to range between £345m and £360m, around 4% higher than the previous guidance of £330m to £345m. The FTSE 250 group

Read more
5 Feb 2015 15:15

BTG Increases Revenue Guidance On Acquisition, Currency Impact Reverse

Read more
4 Feb 2015 11:40

UK WINNERS & LOSERS: Hargreaves Lansdown Hit After Profit Drop

Read more
4 Feb 2015 09:41

UK BROKER RATINGS: Numis Cuts Hargreaves Lansdown To Add From Buy

Read more
8 Jan 2015 10:04

BTG confirms completion of US PneumRx pulmonology business

Specialist healthcare company BTG said it had completed its acquisition of US interventional pulmonology business PneumRx, which will cost the FTSE 250 group up to £315m. The acquisition had been conditional on the expiration or early termination of a waiting period under the Hart-Scott-Rodino Act i

Read more
9 Dec 2014 09:23

Tuesday broker round-up

Aberdeen: Cantor Fitzgerald initiates with a target price of 520p and a 'buy' recommendation. Aggreko: Jefferies reduces target price from 1810p to 1350p, downgrading to 'underperform'. Ashcourt Rowan: Cantor Fitzgerald initiates with a target price of 270p and a 'buy' recommendation. Ashmore: Can

Read more
5 Dec 2014 11:55

Friday tips round-up: DS Smith, BTG

Specialist packaging manufacturer DS Smith has proven adept at growing with its clients, acquiring rivals and moving into new niches and geographies. That has seen the company transformed from a maker of paper into a manufacturer of higher-margin specialist packaging. A case in point is the recent a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.